二、产品特点:
稀有循环肿瘤细胞的数量的人群出现在人类血液很低, 因此CTC评估的有效性取决于 准确的分子目标。细胞数量和相应的分析在采集的血液样本中加入TransFix可以显著延长样本中CTCs的完整性。
稳定后, CTCs 在室温18 - 25℃可持续 5天。
从所有血液中以允许隔离 CTCs方式来稳定细胞（细胞表面标记，尺寸排除方法）。
三、该产品相关文献;
1.Dent, B. M., et al. (2016), High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers. Int. J. Cancer, 138: 206 216. doi:10.1002/ijc.29680
Link: http://onlinelibrary.wiley.com/doi/10.1002/ijc.29680/full
2.David J. et al. (2015) Development of a method to measure acetylated histone H4 in the nuclei of circulating myeloid cells as a surrogate tissue for the pharmacodynamics of HDAC inhibitors in the treatment of solid tumors. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 5374. doi:10.1158/1538-7445.AM2015-5374
Link: http://cancerres.aacrjournals.org/content/75/15_Supplement/5374.short
3.Mu Z. et al. (2016) Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer. Int. J. Mol. Sci. 17(10), 1665; doi:10.3390/ijms17101665
Link: http://www.mdpi.com/1422-0067/17/10/1665/htm
4.Magbanua et al. (2015) A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay. PLoS ONE 10(10): e0141166.
Link: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0141166
5.Fasching et al. (2013) 4EVER: Assessment of circulating tumor cells with a novel, filtration-based method, in a phase IIIb multicenter study for postmenopausal, HER2-negative, estrogen receptor-positive, advanced breast cancer patients. ASCO Meeting Abstracts Jun 17, 2013:591
Link:https://www.researchgate.net/publication/280003424_4EVER_Assessment_of_circulating_tumor_cells_with_a_novel_filtration-based_method_in_a_phase_IIIb_multicenter_study_for_postmenopausal_HER2-negative_estrogen_receptor-positive_advanced_breast_cancer_pa
6.Reduzzi C. et al. (2017) Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors. In: Magbanua M., Park J. (eds) Isolation and Molecular Characterization of Circulating Tumor Cells. Advances in Experimental Medicine and Biology, vol 994. Springer, Cham
Link: https://link.springer.com/chapter/10.1007%2F978-3-319-55947-6_4
产品说明书：https://www.cytomark.co.uk/downloads/REV_CTC-TVT-RUO-EN1.pdf
更多的信息请访问官网https://www.cytomark.co.uk（Cytomark官网）和www.premedlab.com（普瑞麦迪官网），010-51668388-8011或QQ：1793915448期待您的咨询！！！
bio-equip.com
